欧洲肠外营养市场预测至 2030 年 - 区域分析 - 按营养素类型（单剂量氨基酸溶液、肠外脂质乳剂、碳水化合物、微量元素、维生素和矿物质）和最终用户（医院、诊所等）
营养不良和早产病例激增推动欧洲肠外营养市场发展
营养不良包括营养不足、超重或肥胖、维生素或矿物质不足以及因饮食不良而患有非传染性疾病。根据世界卫生组织 (WHO) 的数据，2021 年约有 19 亿成年人超重或肥胖，而 4.62 亿人体重不足。此外，3900 万 5 岁以下儿童超重，1.49 亿儿童因饮食中长期缺乏营养丰富的食物而生长发育迟缓，4500 万人消瘦（身高太瘦）。此外，5 岁以下儿童死亡中约有 45% 与营养不足有关。根据联合国国际儿童紧急基金会 (UNICEF) 2022 年 7 月的数据，营养不足的发生率从 2019 年的 8.0% 达到 2020 年的 9.3%； 2021 年，该比例进一步跃升至 9.8%。
根据欧洲专科营养研究，2019 年欧洲约有 40% 的住院成年患者营养不良。根据 2021 年发表的一项题为“医院营养不良多中心调查”的研究，英格兰医院和家庭护理环境中约有 11-45% 的患者营养不良。根据需要通过肠外方法提供的营养支持是治疗大多数营养不良病例的重要且合适的方法。
早产是指婴儿在相当早的阶段出生，即在怀孕 37 周之前出生。根据世卫组织 2023 年发布的数据，2020 年全球报告的早产病例约为 1340 万例（占出生婴儿总数的十分之一以上）。低收入国家平均有 12% 的婴儿早产，而高收入国家这一比例为 9%。大量早产儿体重过轻且免疫力不发达，危及他们的生命。由于早产并发症导致吸吮或吞咽困难，或由于神经肌肉、心脏或其他疾病，早产儿更倾向于肠外营养。当出生后无法通过肠内途径安全满足估计的能量和营养需求时，肠外营养 (PN) 是早产新生儿和婴儿常规营养护理的一部分。
因此，儿童和成人营养不良的巨大负担以及大量的早产推动了对肠外营养配方和产品的需求，从而推动了市场的发展。
欧洲肠外营养市场概览
在德国，有几起与超重、肥胖和营养不良有关的病例。根据罗伯特·科赫研究所的数据，2022 年约有三分之二的男性和超过一半的女性超重。营养不足会导致恶性肿瘤患者出现不良结果并降低生活质量。活动性肿瘤患者通常缺乏足够的食物；因此，肠外和肠内营养用于预防或减少逐渐减轻的体重。根据德国科学医学协会的说法，患有严重胃肠道缺陷（如放射性肠炎）的患者可以从肠外营养中受益。在大多数情况下，人工营养可以稳定或增加体重和体脂量。
此外，德国幽门螺杆菌感染的发病率很高，这是导致胃癌的重要原因。根据《临床微生物学与感染》杂志 (ELSEVIER) 的一项研究 (2020)，幽门螺杆菌感染了德国约 25% 的总人口，并引起了胃炎，而胃腺癌会变得更加复杂。此外，德国的胃癌发病率很高，这促进了该国的诊断程序。根据国际癌症研究机构的最新数据，德国胃癌的年龄标准化发病率估计为每 100,000 人 7 人，粗发病率为 18.29。上述因素正在推动德国肠外营养市场的发展。
欧洲肠外营养市场收入及预测至 2030 年（百万美元）
欧洲肠外营养市场细分
欧洲肠外营养市场根据营养类型、最终用户和国家进行细分。根据营养类型，欧洲肠外营养市场分为单剂量氨基酸溶液、肠外脂质乳剂、碳水化合物、微量元素以及维生素和矿物质。单剂量氨基酸溶液部分在 2022 年占据了最大的市场份额。
按最终用户划分，欧洲肠外营养市场分为医院、诊所和其他。医院部门在 2022 年占据了最大的市场份额。
根据国家/地区，欧洲肠外营养市场细分为。德国在 2022 年占据了欧洲肠外营养市场份额的主导地位。
ICU Medical Inc、Grifols SA、辉瑞公司、大冢制药有限公司、百特国际公司、B Braun SE、Fresenius Kabi AG、Aculife Healthcare Pvt Ltd 和 Vifor Pharma Management AG 是欧洲肠外营养市场的一些领先参与者。
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Parenteral Nutrition Market - Key Industry Dynamics
4.1 Market Drivers
4.1.1 Rise in Prevalence of Gastrointestinal Diseases
4.1.2 Surge in Cases of Malnutrition and Premature Births
4.2 Market Restraints
4.2.1 Mechanical, Gastrointestinal, and Metabolic Complications Associated with Parenteral Feeding Systems
4.3 Market Opportunities
4.3.1 New Product Developments by Companies
4.4 Future Trends
4.4.1 Innovation in Formulations of Nutrition Products
4.5 Impact Analysis
5. Parenteral Nutrition Market - Europe Market Analysis
5.1 Overview
5.2 Parenteral Nutrition Market Revenue (US$ Mn), 2020 - 2030
6. Europe Parenteral Nutrition Market Analysis - by Nutrient Type
6.1 Overview
6.2 Single Dose Amino Acid Solution
6.2.1 Overview
6.2.2 Single Dose Amino Acid Solution: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
6.3 Parenteral Lipid Emulsion
6.3.1 Overview
6.3.2 Parenteral Lipid Emulsion: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Carbohydrates
6.4.1 Overview
6.4.2 Carbohydrates: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
6.5 Trace Elements
6.5.1 Overview
6.5.2 Trace Elements: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
6.6 Vitamins and Minerals
6.6.1 Overview
6.6.2 Vitamins and Minerals: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
7. Europe Parenteral Nutrition Market Analysis - by End User
7.1 Overview
7.2 Hospitals
7.2.1 Overview
7.2.2 Hospitals: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
7.3 Clinics
7.3.1 Overview
7.3.2 Clinics: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Others
7.4.1 Overview
7.4.2 Others: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
8. Europe Parenteral Nutrition Market - Country Analysis
8.1 Europe
8.1.1 Europe: Parenteral Nutrition Market - Revenue and Forecast Analysis - by Country
8.1.1.1 Germany: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
8.1.1.1.1 Overview
8.1.1.1.2 Germany: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
8.1.1.1.3 Germany: Parenteral Nutrition Market Breakdown, by Nutrient Type
8.1.1.1.4 Germany: Parenteral Nutrition Market Breakdown, by End User
8.1.1.2 United Kingdom: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
8.1.1.2.1 Overview
8.1.1.2.2 United Kingdom: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
8.1.1.2.3 United Kingdom: Parenteral Nutrition Market Breakdown, by Nutrient Type
8.1.1.2.4 United Kingdom: Parenteral Nutrition Market Breakdown, by End User
8.1.1.3 France: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
8.1.1.3.1 Overview
8.1.1.3.2 France: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
8.1.1.3.3 France: Parenteral Nutrition Market Breakdown, by Nutrient Type
8.1.1.3.4 France: Parenteral Nutrition Market Breakdown, by End User
8.1.1.4 Italy: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
8.1.1.4.1 Overview
8.1.1.4.2 Italy: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
8.1.1.4.3 Italy: Parenteral Nutrition Market Breakdown, by Nutrient Type
8.1.1.4.4 Italy: Parenteral Nutrition Market Breakdown, by End User
8.1.1.5 Spain: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
8.1.1.5.1 Overview
8.1.1.5.2 Spain: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
8.1.1.5.3 Spain: Parenteral Nutrition Market Breakdown, by Nutrient Type
8.1.1.5.4 Spain: Parenteral Nutrition Market Breakdown, by End User
8.1.1.6 Rest of Europe: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
8.1.1.6.1 Overview
8.1.1.6.2 Rest of Europe: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
8.1.1.6.3 Rest of Europe: Parenteral Nutrition Market Breakdown, by Nutrient Type
8.1.1.6.4 Rest of Europe: Parenteral Nutrition Market Breakdown, by End User
9. Industry Landscape
9.1 Overview
9.1.1 Overview
10. Company Profiles
10.1 ICU Medical Inc
10.1.1 Key Facts
10.1.2 Business Description
10.1.3 Products and Services
10.1.4 Financial Overview
10.1.5 SWOT Analysis
10.1.6 Key Developments
10.2 Grifols SA
10.2.1 Key Facts
10.2.2 Business Description
10.2.3 Products and Services
10.2.4 Financial Overview
10.2.5 SWOT Analysis
10.2.6 Key Developments
10.3 Pfizer Inc
10.3.1 Key Facts
10.3.2 Business Description
10.3.3 Products and Services
10.3.4 Financial Overview
10.3.5 SWOT Analysis
10.3.6 Key Developments
10.4 Otsuka Pharmaceuticals Co Ltd
10.4.1 Key Facts
10.4.2 Business Description
10.4.3 Products and Services
10.4.4 Financial Overview
10.4.5 SWOT Analysis
10.4.6 Key Developments
10.5 Baxter International Inc
10.5.1 Key Facts
10.5.2 Business Description
10.5.3 Products and Services
10.5.4 Financial Overview
10.5.5 SWOT Analysis
10.5.6 Key Developments
10.6 B Braun SE
10.6.1 Key Facts
10.6.2 Business Description
10.6.3 Products and Services
10.6.4 Financial Overview
10.6.5 SWOT Analysis
10.6.6 Key Developments
10.7 Fresenius Kabi AG
10.7.1 Key Facts
10.7.2 Business Description
10.7.3 Products and Services
10.7.4 Financial Overview
10.7.5 SWOT Analysis
10.7.6 Key Developments
10.8 Vifor Pharma Management AG
10.8.1 Key Facts
10.8.2 Business Description
10.8.3 Products and Services
10.8.4 Financial Overview
10.8.5 SWOT Analysis
10.8.6 Key Developments
10.9 Aculife Healthcare Pvt Ltd
10.9.1 Key Facts
10.9.2 Business Description
10.9.3 Products and Services
10.9.4 Financial Overview
10.9.5 SWOT Analysis
10.9.6 Key Developments
11. Appendix
11.1 About The Insight Partners
11.2 Glossary of Terms
List of Tables
Table 1. Parenteral Nutrition Market Segmentation
Table 2. Germany: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by Nutrient Type
Table 3. Germany: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 4. United Kingdom: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by Nutrient Type
Table 5. United Kingdom: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 6. France: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by Nutrient Type
Table 7. France: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 8. Italy: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by Nutrient Type
Table 9. Italy: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 10. Spain: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by Nutrient Type
Table 11. Spain: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 12. Rest of Europe: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by Nutrient Type
Table 13. Rest of Europe: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 14. Recent Organic Growth Strategies in the Parenteral Nutrition Market
Table 15. Glossary of Terms, Parenteral Nutrition Market
List of Figures
Figure 1. Parenteral Nutrition Market Segmentation, By Country
Figure 2. Parenteral Nutrition Market: Key Industry Dynamics
Figure 3. Parenteral Nutrition Market: Impact Analysis of Drivers and Restraints
Figure 4. Parenteral Nutrition Market Revenue (US$ Mn), 2020 - 2030
Figure 5. Parenteral Nutrition Market Share (%) - by Nutrient Type (2022 and 2030)
Figure 6. Single Dose Amino Acid Solution: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Parenteral Lipid Emulsion: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Carbohydrates: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Trace Elements: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Vitamins and Minerals: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Parenteral Nutrition Market Share (%) - by End User (2022 and 2030)
Figure 12. Hospitals: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Clinics: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Others: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Europe: Parenteral Nutrition Market, by Key Country - Revenue (2022) (US$ Million)
Figure 16. Europe: Parenteral Nutrition Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 17. Germany: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million)
Figure 18. United Kingdom: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million)
Figure 19. France: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million)
Figure 20. Italy: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million)
Figure 21. Spain: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million)
Figure 22. Rest of Europe: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million)
1. ICU Medical Inc
2. Grifols SA
3. Pfizer Inc
4. Otsuka Pharmaceuticals Co Ltd
5. Baxter International Inc
6. B Braun SE
7. Fresenius Kabi AG
8. Aculife Healthcare Pvt Ltd
9. Vifor Pharma Management AG
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe parenteral nutrition market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Europe parenteral nutrition market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the Europe parenteral nutrition market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.